About Index Trending news
Analyze
Pricing
Tissue Regenix

Tissue Regenix

Work at Tissue Regenix? Add yourself to this profile

Tissue Regenix

Tissue Regenix uses its patented dCELL® technology to address many clinical needs such as sports medicine, wound care and heart valve replacement.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding
Undisclosed funding
$1,349,658
Employees

Team size

50+
Locations
HQ
Acquisition
Xconomy

San Antonio’s CellRight Sells to U.K. Medical Company Tissue Regenix

Science